Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Canoll

Showing results (81-90 of 233) with videos related to

Pageof 24
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastomaAllen Waziri, Brendan Killory, Alfred T Ogden, et al.
Journal of Neurosurgery. Pediatrics|May 2, 2008
Intraorbital and intracranial soft-tissue glomus tumor in an 8-year-old child. Case reportTodd C Hankinson, Alfred T Ogden, Peter Canoll, et al.
Cancer Research|April 6, 2011
Convection-enhanced delivery of topotecan into a PDGF-driven model of glioblastoma prolongs survival and ablates both tumor-initiating cells and recruited glial progenitorsKim A Lopez, Aaron M Tannenbaum, Marcela C Assanah, et al.
Acta Neuropathologica|January 16, 2007
Expression patterns of LIS1, dynein and their interaction partners dynactin, NudE, NudEL and NudC in human gliomas suggest roles in invasion and proliferationSatoshi O Suzuki, Richard J McKenney, Shin-ya Mawatari, et al.
Human Molecular Genetics|December 4, 2012
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastomaPedro M Costa, Ana L Cardoso, Clévio Nóbrega, et al.
Neuro-Oncology|June 11, 2013
Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastomaJonathon J Parker, Kalen R Dionne, Rada Massarwa, et al.
Molecular Biology of the Cell|January 6, 2012
Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogensSanja Ivkovic, Christopher Beadle, Sonal Noticewala, et al.
Neuro-Oncology Advances|May 22, 2023
Convection-enhanced delivery of immunomodulatory therapy for high-grade gliomaColin P Sperring, Michael G Argenziano, William M Savage, et al.
Biomedicines|November 27, 2025
The Role of mTOR Signaling in Tumor-Induced Alterations to Neuronal Function in Diffusely Infiltrating GliomaHannah Haile, Sandra Leskinen, Arjun R Adapa, et al.
Frontiers in Oncology|December 7, 2020
Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-CareLee Curtin, Paula Whitmire, Cassandra R Rickertsen, et al.
Pageof 24

Showing results (81-90 of 233) with videos related to

Sort By:
Pageof 24
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastomaAllen Waziri, Brendan Killory, Alfred T Ogden, et al.
Journal of Neurosurgery. Pediatrics|May 2, 2008
Intraorbital and intracranial soft-tissue glomus tumor in an 8-year-old child. Case reportTodd C Hankinson, Alfred T Ogden, Peter Canoll, et al.
Cancer Research|April 6, 2011
Convection-enhanced delivery of topotecan into a PDGF-driven model of glioblastoma prolongs survival and ablates both tumor-initiating cells and recruited glial progenitorsKim A Lopez, Aaron M Tannenbaum, Marcela C Assanah, et al.
Acta Neuropathologica|January 16, 2007
Expression patterns of LIS1, dynein and their interaction partners dynactin, NudE, NudEL and NudC in human gliomas suggest roles in invasion and proliferationSatoshi O Suzuki, Richard J McKenney, Shin-ya Mawatari, et al.
Human Molecular Genetics|December 4, 2012
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastomaPedro M Costa, Ana L Cardoso, Clévio Nóbrega, et al.
Neuro-Oncology|June 11, 2013
Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastomaJonathon J Parker, Kalen R Dionne, Rada Massarwa, et al.
Molecular Biology of the Cell|January 6, 2012
Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogensSanja Ivkovic, Christopher Beadle, Sonal Noticewala, et al.
Neuro-Oncology Advances|May 22, 2023
Convection-enhanced delivery of immunomodulatory therapy for high-grade gliomaColin P Sperring, Michael G Argenziano, William M Savage, et al.
Biomedicines|November 27, 2025
The Role of mTOR Signaling in Tumor-Induced Alterations to Neuronal Function in Diffusely Infiltrating GliomaHannah Haile, Sandra Leskinen, Arjun R Adapa, et al.
Frontiers in Oncology|December 7, 2020
Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-CareLee Curtin, Paula Whitmire, Cassandra R Rickertsen, et al.
Pageof 24